OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
blood
OMRF launches world’s first lupus prevention study
The SMILE trial will seek to identify individuals at high risk for developing lupus and treat them before they ever transition into the disease.
OMRF-OUHSC student receives dual-degree NIH grant
OMRF’s Christopher Hoover became just the second Oklahoman in 30 years to earn a prestigious Kirschstein service award.
Oklahoma researchers zero in on cause of blood disorder
New findings could help scientists develop treatments for the condition known as ITP.
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.
OMRF researcher tests new approach for treating deadly blood infection
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.
